STMicroelectronicsT410-600B-TRTRIACs

TRIAC 600V 4A(RMS) 31A 3-Pin(2+Tab) DPAK T/R

This triac T410-600B-TR thyristor manufactured from STMicroelectronics acts as a bistable switch and will continue to operate when a voltage is applied to it. This device has a surge current rating of 31 A. This product will be shipped in tape and reel packaging to allow for quick mounting and safe delivery. This SCR thyristor has an operating temperature range of -40 °C to 125 °C. Its repetitive peak forward blocking voltage is 600 V, while its repetitive peak reverse voltage is 600 V.

Import TariffMay apply to this part

Total In Stock: 140,259 parts

Regional Inventory: 10,259

    Total$0.25Price for 1

    10,259 In stock: Ships in 2 days

    • Service Fee  $7.00

      Ships in 2 days

      Ships from:
      United States of America
      Date Code:
      2228+
      Manufacturer Lead Time:
      15 weeks
      Minimum Of :
      1
      Maximum Of:
      2499
      Country Of origin:
      China
         
      • Price: $0.2547
      Spliced leader/trailer tape per EIA standards Leader tape:400mm=15.75'; Trail tape:160mm=6.3' more information
    • Ships in 2 days

      Ships from:
      United States of America
      Date Code:
      2228+
      Manufacturer Lead Time:
      15 weeks
      Country Of origin:
      China
      • In Stock: 259 parts
      • Price: $0.2547
    • (2500)

      Ships in 2 days

      Increment:
      2500
      Ships from:
      United States of America
      Date Code:
      2452+
      Manufacturer Lead Time:
      15 weeks
      Country Of origin:
      China
      • In Stock: 10,000 parts
      • Price: $0.1804
    • (5000)

      Ships in 3 days

      Ships from:
      Netherlands
      Date Code:
      2523+
      Manufacturer Lead Time:
      15 weeks
      Country Of origin:
      France
      • In Stock: 130,000 parts
      • Price: $0.2274

    Design AI-powered medical devices

    Explore system design tips, part recs and AI insights to help you build faster, safer diagnostic and therapy solutions—all in Arrow’s latest white paper.